Kyverna Therapeutics Email Formats

Biotechnology Research • Emeryville, California, United States • 101-200 Employees

Kyverna Therapeutics Email Formats

Kyverna Therapeutics uses 4 email formats. The most common is {first initial}{last name} (e.g., jdoe@kyvernatx.com), used 54.9% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@kyvernatx.com	54.9%
{first name}{last name}	johndoe@kyvernatx.com	38.9%
{last name}{last name}	doedoe@kyvernatx.com	3.5%
{first initial}{second initial}{last name}	jodoe@kyvernatx.com	1.8%

Key Contact at Kyverna Therapeutics

Warner Biddle

Chief Executive Officer

Mobile @kyvernatx.com

Company overview

Headquarters	5980 Horton St, Suite 550, Emeryville, California 94608, US
Website	kyvernatx.com
NAICS	541714
SIC	873
Keywords	Multiple Sclerosis, Cell Therapy, Lupus, Autoimmune, Scleroderma, Myasthenia Gravis, Car T-Cell, Systemic Sclerosis, Stiff-Person Syndrome
Founded	2018
Employees	101-200
Socials

About Kyverna Therapeutics

Kyverna is a patient-centered, clinical-stage biopharmaceutical company focused on developing cell therapies for patients suffering from autoimmune diseases. Our lead product candidate, KYV-101 is advancing through clinical development across two broad areas of autoimmune disease: rheumatology and neurology, including Phase 2 trials for stiff-person syndrome, multiple sclerosis and myasthenia gravis, a Phase 1/2 trial for systemic sclerosis, and two ongoing multi-center, open-label Phase 1/2 trials in the United States and Germany for patients with lupus nephritis. Kyverna’s pipeline includes next-generation chimeric antigen receptor (CAR) T-cell therapies in both autologous and allogeneic formats with properties intended to be well suited for use in B cell-driven autoimmune diseases.

Employees by Management Level

Total employees: 101-200

Seniority

Employees

Director

Manager

Entry

Employees by Department

Kyverna Therapeutics has 76 employees across 11 departments.

Departments

Number of employees

Funding Data

Explore Kyverna Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2023-09-03	5	$60,000,000

Funding Insights

$60,000,000

Total funding amount

$60,000,000

Most recent funding amount

Number of funding rounds

Kyverna Therapeutics Tech Stack

Discover the technologies and tools that power Kyverna Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Gravity Forms

Form builders

ScrollMagic

JavaScript libraries

lit-element

JavaScript libraries

Google Maps

Maps

lit-html

JavaScript libraries

jQuery Migrate

JavaScript libraries

Cloudflare

CDN

jQuery

JavaScript libraries

Apple iCloud Mail

Webmail

PHP

Programming languages

WP-PageNavi

WordPress plugins

WordPress

Blogs

Frequently asked questions

Kyverna Therapeutics is located in Emeryville, California, US.

Kyverna Therapeutics was founded in 2018, making it 8 years old. The company has established itself as a significant player in its industry over this time.

Kyverna Therapeutics has approximately 101-200 employees. The company continues to grow its workforce to support its business operations and expansion.

Kyverna Therapeutics has raised a total of $60,000,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contact at Kyverna Therapeutics

Warner Biddle

Chief Executive Officer

Mobile @kyvernatx.com

4.8

40,000 users